Fitxa persona

RUBEN DARIO ARTERO ALLEPUZ
PDI-Catedratic/a d'Universitat

ruben.artero@uv.es
http://www.uv.es/artero

Àrea de coneixement: GENÈTICA
Departament: Genètica

(9635) 43028

Biografia

[Biografia, versió en valencià]

Asignatures impartides i modalitats docents

43460 - Tècniques d'anàlisi i quantificació - Màster Universitari en Investigació en Biologia Molecular, Cel.lular i Genètica	Aula Informàtica, Laboratori, Uns altres
43462 - Fonaments en expressió gènica - Màster Universitari en Investigació en Biologia Molecular, Cel.lular i Genètica	Teoria

Tutories

Anual

Dilluns de 09:00 a 12:00. DESPACHO EN LA SEXTA PLANTA DEL BLOQUE B DE LA FACULTAD DE BIOLOGIA

Observacions

Participa en el programa de tutories electròniques de la Universitat de València

Publicacions en revistes

Activitats anteriors

Estades a Centres de Recerca

Participacions a Congressos

Natalia Riedel; Ariadna Bargiela Schönbrunn; Rubén Artero; Manuel Pérez Alonso (2023). 'Development of gapmers against MSI2, a new therapeutic target against muscle atrophy in myotonic dystrophy type 1'. (Poster). Final Meeting COST DARTER Bilbao 2023 . ESPANYA
Giovanna Menduti; Camille Januel; Cristina Ruatti; Noémie Berenger-Currias; Cecile Martinat; Rubén Artero; Piotr Konieczny; Marina Boido. (2023). Uncovering repositioned therapies' efficacy for Spinal Muscular Atrophy treatment. (Ponència). 20th National Congress of the Italian Society for Neuroscience . Turin . ITÀLIA
Andrea García-Rey; Estefanía Cerro-Herreros; Judit Núñez-Manchón; Neia Naldaiz-Gastes; Marc Carrascosa-Sàez, Irene González-Martínez; Javier Poyatos-García; Juan J Vilchez; Adolfo López de Munain; Mònica Suelves; Gisela Nogales-Gadea; Beatriz Llamusí; Rubén Artero (2022). AntimiR-23b based therapy rescues MBNL1-dependent splicing patterns in a range of Myotonic Dystrophy genetic backgrounds. (Poster). ConBioPreVal. Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . ESPANYA
Anna Colom-Rodrigo; Irene González-Martínez; Arturo López-Castel; Estefanía Cerro-Herreros; Ruben Artero (2022). Involvement of miR-23b and miR-218 in the pathogenesis of Myotonic Dystrophy type 1. (Poster). ConBioPreVal. Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . ESPANYA
Marta SELVA-GIMÉNEZ; Javier POYATOS-GARCIA; Águeda BLÁZQUEZ-BERNAL; Ariadna BARGIELA; Jorge ESPINOSA-ESPINOSA; Rafael P. VÁZQUEZ-MANRIQUE; Anne BIGOT; Ruben ARTERO; Juan Jesús VILCHEZ (2022). CRISPR-Cas9 editing of the TNPO3 mutation causing Limb-Girdle Muscular Dystrophy type D2 in a muscle cell model. (Ponència). VIII. International Istambul Scientific Research Congress . Estambul . TURQUIA
Ariadna BARGIELA; Amadeo TEN; Luis Marti BONMATI; Teresa SEVILLA; Ruben ARTERO (2022). In vivo study of muscle dysfunction in myotonic dystrophy mice by quantitative nuclear magnetic resonance imaging. (Ponència). VIII. International Istambul Scientific Research Congress . Estambul . TURQUIA
Ariadna Bariela Schönbrunn; Manuel Pérez Alonso; Rubén Artero (2022). Fomentar el aprendizaje significativo mediante la adquisición de competencias por medio del uso de un cuaderno de laboratorio electrónico. (Comunicació). Congreso Internacional de Innovación Educativa en Educación Superior . Bilbao . ESPANYA
Agueda Blázquez, Javier Poyatos, Marta Selva, Juan Vílchez, Ruben Artero, Ariadna Bargiela (2022). CRISPR-Cas9 EDITING OF TNPO3 MUTATION IN THE FIRST CELL MODEL OF Limb-Girdle MUSCULAR DYSTROPHY TYPE D2. (Ponència). 5TH INTERNATIONAL CONGRESS ON LIFE, SOCIAL, AND HEALTH SCIENCES IN A CHANGING WORLD . TURQUIA
Javier Poyatos-Garcia; Águeda Blázquez-Bernal; Marta Selva-Giménez; Ariadna Bargiela; Rafael P. Vázquez-Manrique; Anne Bigot; Ruben Artero; Juan Jesús Vilchez (2022). TNPO3 c.2771delA edition by CRISPR-Cas9 in a muscle cell model of Limb-Girdle Muscular Dystrophy type D2. (Poster). 7th International Myology Congress . Nice . FRANÇA
J Espinosa Espinosa; E. Cerro Herreros; I González Martínez; N Moreno; SJ Overby; B Llamusi; Ruben Artero (2022). Comprehensive transcriptomic characterization of antisense RNA treatments effects on Myotonic dystrophy type 1 cell models. (Ponència). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPÓ
I González Martínez; E Cerro Herreros; N Moreno Cervera; A García Rey; M Carrascosa Saez; A Arzumanov; D Seoane; M Fischer; Y Jad; R Raz; MA Varela; MJ Wood; B Llamusi; R Artero (2022). Peptide conjugated antimiRs rescue Myotonic Dystrophy phenotypes in animal and cell models by promoting MBNL1 expression. (Poster). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPÓ
M Sabater Arcís; N Moreno; A Bargiela; R Artero (2022). Musashi-2 overexpression contributes to myotonic dystrophy muscle dysfunction by the repression of miR-7 biogenesis. (Poster). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPÓ
Ariadna Bargiela; Amadeo Ten; Luis Martí Bonmatí; Teresa Sevilla; Rubén Artero (2022). Quantitative nuclear magnetic resonance imaging, a tool for in vivo study of muscle dysfunction in myotonic dystrophy model mice. (Ponència). V International New York Academic Research Congress. Online . New York . ESTATS UNITS D'AMÈRICA
Estefanía Cerro-Herreros; Judit Núñez-Manchón; Neia Naldaiz-Gastesi; Marc Carrascosa-Sàez; Andrea García-Rey; Irene González-Martínez; Kevin Moreno; Javier Poyatos-García; Juan J Vilchez; Adolfo López de Munain; Mònica Suelves; Gisela Nogales-Gadea; Beatriz Llamusí; Rubén Artero (2022). Lead antimiR-23b drug rescues cell phenotypes in a range of Myotonic Dystrophy genetic backgrounds. (Poster). 2022 Myotonic Dystrophy Foundation (MDF) Annual Conference . San Diego . ESTATS UNITS D'AMÈRICA
Nerea Moreno, Maria Sabater-Arcis, Ariadna Bargiela, Ruben Artero (2022). Musashi-2 overexpression enhances atrophy phenotypes in vivo by miR-7 repression. (Poster). 1st FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference entitled "The perfect tandem: How technology expands the frontiers of biomedicine' . Sevilla . ESPANYA
Natalia Riedel; Ariadna Bargiela Schönbrunn; Rubén Artero; Manuel Pérez Alonso (2022). "Development of gapmers against MSI2, a new therapeutic target against muscle atrophy in myotonic dystrophy type 1". (Poster). 1st FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference . Sevilla . ESPANYA
Carlos Casillas-Serra; Estela Selma-Soriano; Ruben Artero; Juan Antonio Navarro; Josep Redón (2021). Rabphilin silencing causes dilated cardiomyopathy in a Drosophila´s human model of cardiac-nephrocyte damage. (Poster). Sociedad Española de Genética . ESPANYA
Águeda Blázquez Bernal; Juan M. Fernandez Costa; Ariadna Bargiela; Ruben Artero (2021). Development of a Drosophila model of LGMD1F and drug screening. (Poster). 62nd Annual Drosophila Research Conference . ESTATS UNITS D'AMÈRICA
Beatriz Llamusi, Ruben Artero, Estefania Cerro-Herreros, Irene González-Martinez, Nerea Moreno-Cervera, Sarah Overby, Manuel Perez-Alonso (2021). Development of an antimiR-based treatment against Myotonic Dystrophy disease. (Poster). Noncoding RNA World: From Mechanism to Therapy . SUÏSSA
Bargiela, Ariadna; Sabater-Arcis, Maria, and Artero, Ruben (2021). Repression of miR-7 by Musashi-2 leads to increased autophagy and muscle dysfunction in myotonic dystrophy type 1. (Poster). New Directions in Biology and Disease of Skeletal Muscle Conference . Charleston . ESTATS UNITS D'AMÈRICA
Ariadna Bargiela , Maria Sabater, Ruben Artero (2021). Contribution of Musashi-2 to muscle dysfunction in myotonic dystrophy by upregulating autophagy through miR-7 biogenesis repression. (Poster). Noncoding RNA World: From Mechanism to Therapy . SUÏSSA
Giovanna Menduti, Piotr Konieczny, Camille Januel, Cecile Martinat, Ruben Artero, Marina Boido (2021). Drug repositioning strategy in Spinal Muscular Atrophy: therapeutic effects of the antibiotic Moxifloxacin in SMNΔ7 mice. (Poster). 4th Brainstorming Research Assembly for Young Neuroscientists . Pisa . ITÀLIA
Sabater-Arcis M; Bargiela A; Furling D; Artero R (2021). Effects of miR-7 modulation on muscle atrophy-related phenotypes in myotonic dystrophy. (Ponència invitada). RNAi 2021 . Oxford (Online) . REGNE UNIT
Águeda Blázquez-Bernal; Javier Poyatos-Garcia; Marta Selva-Gimenez; Ariadna Bargiela; Juan J. Vilchez; Ruben Artero (2021). Characterization of cell model of LGMDD2 and validation of candidate therapies. (Comunicació). V International LGMD1F-D2 Congress . ESPANYA
Sarah Overby; Estefanía Cerro-Herreros, Irene González-Martínez, Miguel Varela, Matthew Wood, Beatriz Llamusí, Ruben Artero (2021). BlockmiR induced MBNL rescue in DM1 models. (Poster). Oligonucleotide Therapeutics Society Annual Meeting . Virtual . ESTATS UNITS D'AMÈRICA
Irene González-Martínez; Estefanía Cerro-Herreros; Nerea Moreno-Cervera; Sarah Overby; Manuel Pérez-Alonso; Beatriz Llamusí; Rubén Artero (2020). Therapeutic potential of antagomiR-23b for treating Myotonic Dystrophy. (Poster). IV Congreso Nacional de Jóvenes Investigadores en Biomedicina . ESPANYA
Águeda Blázquez-Bernal; Ariadna Bargiela; Rubén Artero, (2020). Development of a Drosophila model of LGMD1F, an ultra-rare genetic disease that protects against HIV. (Comunicació). IV Congreso Nacional de Jóvenes Investigadores en Biomedicina . ESPANYA
Maria Sabater-Arcis; Ariadna Bargiela; Alejandro Arco-Hierves; Denis Furling; Ruben Artero (2020). miR-7 levels contribute to the regulation of muscle catabolism in myotonic dystrophy type 1. (Poster). IV Congreso Nacional de Jóvenes Investigadores en Biomedicina . ESPANYA
Piotr Konieczny; Rubén Artero (2020). Drug repurposing for development of combinatorial therapies for SMA. (Poster). 2nd International Scientific & Clinical Congress on Spinal Muscular Atrophy . Paris-Evry . FRANÇA
Beatriz Llamusi, Estefania Cerro-Herreros, Irene González-Martínez, Nerea Moreno-Cervera, Sarah Overby, Manuel Pérez-Alonso, Rubén Artero (2020). Therapeutic potential of antagomiR-23b for treating Myotonic Dystrophy. (Comunicació). 16th Annual Meeting of the Oligonucleotide Therapeutics Society . ESTATS UNITS D'AMÈRICA
Sarah Overby, Estefania Cerro-Herreros, Beatriz Llamusi, Ruben Artero (2020). Proof of concept of blockmiR induced MBNL rescue in DM1 models. (Comunicació). 16th Annual Meeting of the Oligonucleotide Therapeutics Society . ESTATS UNITS D'AMÈRICA
Beatriz Llamusi; Estefanía Cerro-Herreros; Irene González-Martínez; Nerea Moreno-Cervera; Sarah Overby; Manuel Pérez-Alonso; Rubén Artero (2020). Therapeutic potential of antagomiR-23b for treating Myotonic Dystrophy. (Poster). TIDES Europe: Oligonucleotide & Peptide Therapeutics . UNIÓ EUROPEA
Piotr Konieczny; Rubén Artero (2020). From flies to mice: evaluation of combinatorial therapy for SMA. (Comunicació). Motor Neuron Diseases. Understanding the pathogenetic mechanisms to develop therapies . ITÀLIA
Águeda Blázquez-Bernal; Ariadna Bargiela; Rubén Artero (2020). Drug screening in Drosophila model of LGMD1F. (Comunicació). IV International LGMD1F Congress . ESPANYA
Jorge Espinosa, Estefanía Cerro-Herreros, Nerea Moreno, Irene González Martínez, Beatriz Llamusi, Rubén Artero (2019). Therapeutic potential of antimiR-23b and -218 for treating myotonic dystrophy using an RNA-seq approximation. (Poster). III Congress of Young Researchers in Biomedicine . Valencia . ESPANYA
Águeda Blázquez-Bernal, Juan M. Fernández-Costa, Estela Selma-Soriano, Rubén Artero (2019). A Drosophila melanogaster model for LGMD1F. (Poster). III Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . ESPANYA
Águeda Blázquez-Bernal, Juan M. Fernández-Costa, Estela Selma-Soriano, Rubén Artero (2019). Modelo de LGMD1F en Drosophila melanogaster. (Poster). Acto de Alianza de Investigación Traslacional de Enfermedades Raras de la Comunidad Valenciana . Valencia . ESPANYA
Estela Selma Soriano; Manuel Perez Alonso; Ruben Artero (2019). Drug discovery in a Drosophila model of myotonic dystrophy neurodegeneration. (Comunicació). IX Congreso Internacional de Medicamentos Huérfanos y Enfermedades Raras . Sevilla . ESPANYA
Piotr Konieczny, Ruben Artero (2019). Drosophila SMN2 spliceosensor model identifies a candidate therapy for SMA. (Poster). IX Congreso Internacional de Medicamentos Huérfanos y Enfermedades Raras . Sevilla . ESPANYA
Estefania Cerro Herreros; Irene González Martínez; Nerea Moreno; Sarah J Overby; Jorge Espinosa; Beatriz Llamusi; Rubén Artero (2019). ARTHEX-DM, antisense RNA therapeutics in Myotonic Dystrophy. (Comunicació). IX Congreso Internacional de Medicamentos Huérfanos y Enfermedades Raras . Sevilla . ESPANYA
Juan M. Fernandez-Costa; Xiomara Fernandez-Garibay; Ruben Artero; Javier Ramon-Azcon (2019). Generation of human 3D skeletal muscle through bioengineering for preclinical research in Myotonic Dystrophy. (Poster). 2nd IBEC-ICMS Joint Symposium . Barcelona . ESPANYA
Juan M. Fernandez-Costa; Xiomara Fernandez-Garibay; Ruben Artero; Javier Ramon-Azcon (2019). Generation of human 3D skeletal muscle through bioengineering for preclinical research in Myotonic Dystrophy. (Poster). 12th IBEC Symposium . Barcelona . ESPANYA
Rubén Artero (2019). miRNA-based therapeutics for Myotonic Dystrophy. (Ponència invitada). 248 European Neuromuscular Centre Workshop ' Myotonic dystrophies, molecular approaches for clinical purposes. Framing a European molecular research network' . Amsterdam . PAÏSOS BAIXOS
Ariadna Bargiela, Maria Sabater-Arcis, Marc Carrascosa, Raul Jiménez, and Ruben Artero. (2019). Increased Muscleblind levels by Chloroquine treatment Improves Myotonic Dystrophy type 1 phenotypes in in vitro and in vivo models. (Comunicació). International Myotonic Dystrophy Consortium Meeting (IDMC-12) . Gothenburg . SUÈCIA
Ruben Artero, Maria Sabater Arcis, Ariadna Bargiela. (2019). miR-7 restores phenotypes in myotonic dystrophy myoblasts by repressing hyperactivated autophagy. (Comunicació). International Myotonic Dystrophy Consortium Meeting (IDMC-12) . Gothenburg . SUÈCIA
Maria Sabater, Ariadna Bargiela, Ruben Artero (2019). miR-7 levels contribute to the regulation of muscle catabolism in myotonic dystrophy type 1. (Poster). 15th Annual Meeting of the Oligonucleotide Therapeutics Society . Munich . ALEMANYA
Águeda Blázquez-Bernal; Juan M. Fernández-Costa; Ariadna Bargiela; Rubén Artero (2019). A Drosophila melanogaster model for LGMD1F: an update. (Comunicació). III International LGMD1F Congress . Madrid . ESPANYA
Konieczny Piotr, Artero Rubén (2018). Repurposing of drugs using SMN2 Drosophila spliceosensor model. (Poster). International Scientific Congress on Spinal Muscular Atrophy . Kraków . POLÒNIA
Piotr Konieczny, Ruben Artero (2018). Repurposing of drugs using SMN2 Drosophila spliceosensor model. (Poster). 22nd Annual Spinal Muscular Atrophy Researcher Meeting . Dallas, Texas . ESTATS UNITS D'AMÈRICA
Estefania Cerro-Herreros, Sarah Overby , Irene Gonzalez-Martinez, Beatriz Llamusi, Ruben Artero (2018). FANA Oligonucleotides-Based Therapy Targeting microRNAs in Myotonic Dystrophy. (Poster). OTS 2018 Oligo Meeting ( 14th Annual Meeting of the Oligonucleotide Therapeutics Society) . Seattle . ESTATS UNITS D'AMÈRICA